Announcements

31 July 2025
MDPI INSIGHTS: The CEO's Letter #25 - 8,000 Staff Worldwide, Korea Visit, 100,000 Preprints, Malaysia Roundtable, Canada Consortium Deal

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Talent Drives Our Progress

For the first time in MDPI’s history, we now have over 8,000 colleagues across the company. I would like to take a moment to celebrate this milestone and acknowledge the driving force behind our growth and success: our people.

As the world’s leading fully open access publisher, MDPI has grown thanks to the dedication, talent, and teamwork of colleagues across the company. Already halfway through 2025, we’ve welcomed nearly 2,000 new colleagues. 

“Our achievements are also about the people behind them”

We now manage over 475 journals, with 298 receiving an Impact Factor, and hundreds more indexed in major databases, including 343 in Scopus, and 92 by PubMed. As the reach and impact of our journals continues to grow, so does the need for dedicated and qualified teams to support that growth. Thus, attracting and retaining exceptional talent remains a cornerstone of our success.

Our achievements are not just about the results of journal expansion, however: they’re about the people behind them. From our hardworking editors to our meticulous English editing and production teams – from our journal relationship specialists, public relations, marketing and communications professionals to our conference teams and the project teams behind Preprints, Scilit, SciProfiles, JAMS and more. Our success reflects the work of thousands of people showing up each day, taking pride in their work, and committed to excellence and service.

What we’re doing to support talent:

  • Investing in onboarding and training to help new colleagues feel welcomed and empowered to thrive.
  • Creating clearer career paths across all functions, from editorial to communications and beyond.
  • Launching mentorship programs and internal knowledge-sharing sessions to promote growth and collaboration.
  • Evolving our recognition and rewards programs to better celebrate your contributions.
  • Expanding our training systems and platforms.

MDPI’s in-house training department offers over 215 training courses, covering topics from editorial development to cross-cultural collaboration. In 2024 alone, we had 44 full-time trainers and 196 part-time training assistants supporting the learning and development needs of colleagues worldwide. These efforts ensure our teams are equipped with the skills and confidence to grow professionally and contribute meaningfully.

Over two-thirds of our workforce is editorial, and of our more than 5,400 editors, 87% hold a Master’s degree and 6% a PhD. Their collective contributions are central to delivering a high-quality publishing experience and supporting global academic communication.

As we celebrate this milestone, we also aim to continue on a path of steady and sustainable growth, one that balances journal expansion with investment in people, outreach, processes, and innovation. Together, we are shaping the future of open access and academic publishing. Thank you for your hard work, your ideas, and your commitment to serving the global research community.

Let’s continue working together to create a culture where great talent grows and every colleague feels valued.

Impactful Research

Visiting South Korea: Building Connections and Supporting the MDPI Seoul Office

In July, I had the opportunity to visit our team in Seoul and engage directly with academic communities in South Korea. The visit focused on deepening MDPI’s relationships with local universities, institutions, and partners, and supporting the great work of our colleagues at the MDPI Seoul office.

Korea Association of Private University Libraries (KAPUL) Conference

A highlight of the visit was our participation in the Korea Association of Private University Libraries (KAPUL) Conference, where we presented to over 100 academic librarians. I delivered a keynote speech titled “The Evolving Publishing Landscape: Open Access and Beyond,” while my colleague Dr. Jisuk Kang (Public Affairs Specialist) shared insights in her presentation, “Inside MDPI: Editorial Practices & Research Integrity.”

Facts & Figures: South Korea

  • South Korea is MDPI’s sixth-largest publishing country by article volume (over 90,000 MDPI papers published to date).
  • In 2024, Korea ranked 16th globally by total publications, and 6th (among these top 20 countries) by citation impact.
  • 52% of Korean publications in 2024 were OA – and 73% of those were Gold OA.
  • MDPI published about 20% of all OA papers from Korea in 2024.
  • Over 2,000 active Editorial Board Members from South Korea contribute to MDPI journals, with 11 Section Editors-in-Chief.
  • We currently have 11 Institutional Open Access Program agreements and two society partnerships in Korea:
    • Korean Society of Pharmaceutical Sciences and Technology (with MDPI journal Pharmaceutics)
    • Korean Tribology Society (with MDPI journal Coatings)

MDPI Seoul Office and the First Korea Salon

Our Seoul office serves as a regional hub for marketing, communications, and community engagement. It continues to grow in size and influence, prioritizing supporting scholar visits, conference sponsorships, and outreach events such as the recent MDPI Korea Salon.

The inaugural Salon, themed “Exploring Research Trends in Medical Publishing, Ethics, and AI,” brought together over 20 scholars and Editorial Board members serving MDPI journals.

Thank you to our guest speakers including Professors Young-Joon Surh of Seoul National University, Kwang-Sig Lee of Korea University, and Jin-Won Noh of Yonsei University who presented on the landscape of medicine in South Korea and across the globe. The Salon also included presentations from MDPI colleagues on Open Access, ethics, and how the IOAP can support researchers in this field.

“Our Seoul office continues to grow in size and influence”

Looking Ahead

MDPI is already the leading OA publisher in South Korea, yet challenges and misconceptions around OA and APCs remain. Visits like this one, along with the ongoing efforts of our Seoul office, are important to building understanding, trust, and long-term relationships with the local academic community.

A big thank-you to our colleagues in Seoul for their warm hospitality, professionalism, and energy! Our new office is well situated, staffed, and ready to grow. This visit marked an important step forward in our continued mission to support global research communities and advance Open Science.

Inside MDPI

Preprints.org Reaches 100,000 Preprints: A Major Milestone for MDPI and Open Science

In case you missed it, Preprints.org recently surpassed 100,000 preprints posted. This is a major milestone for our platform and one worth celebrating.

Preprints are a key pillar of the Open Science movement, which promotes transparency, equity, and faster knowledge-sharing through initiatives such as Open Access, Open Data, Open Source, and Open Peer Review. The benefits of Open Science extend beyond researchers, as they support funders, educators, policymakers, and the public in advancing discovery and innovation.

What is behind the 100,000 preprints milestone?

Since its launch in 2016, Preprints.org has grown into one of the world’s leading preprint platforms, now ranked fifth globally by publication volume.

More than 350,000 researchers have contributed, helping shape this dynamic and collaborative space for sharing early-stage research across all disciplines.

Read the full announcement here:
https://www.mdpi.com/about/announcements/12202

“Preprints.org has grown into one of the world’s leading preprint platforms”

Some quick facts worth noting:

  • About 56% of the preprints on Preprints.org are later published in peer-reviewed journals.
  • The platform is now indexed in Web of Science (Preprint Citation Index), Europe PMC, and Crossref, helping improve visibility and trust in the preprints shared.
  • Recent upgrades – including a revamped website, new features such as search subscriptions, curated reading lists, and community feedback tools (PREreview) – show our commitment to developing Preprints.org in line with researchers’ needs.

This growth and progress would not be possible without the dedication of the Preprints.org team, our Advisory Board members, screeners, and colleagues across MDPI who support the platform’s development. This milestone is a reminder of our shared mission: to accelerate scientific communication and build a more open, transparent, and inclusive research ecosystem.

I’m excited to see what’s ahead as we approach Preprints.org’s 10-year anniversary in 2026!

Coming Together for Science

Malaysia Media Roundtable: Educating on Open Access and MDPI’s Presence in Southeast Asia

At the end of June, I had the opportunity to participate in a strategic media roundtable in Kuala Lumpur, focused on raising awareness about the importance of Open Access (OA) and on MDPI’s growing presence in Southeast Asia.

We welcomed five Malaysian media outlets for an engaging private session that included presentations and open discussion.

I gave an overview of the benefits of Open Access, MDPI’s global developments, and our collaborations in Malaysia.

My colleague Yu Nwe Soe (Public Relations Specialist), presented on our editorial process, helping to clarify how MDPI supports authors and maintains research quality.

We were also joined by two local Editorial Board Members (EBMs) who offered first-hand insights into their experiences working with MDPI and how OA has shaped their publishing choices.

The discussion covered a range of questions from the press, from OA publishing models to editorial standards, and highlighted MDPI’s unique contribution to accelerating scientific communication in the region.

As the leading fully OA publisher, we see it as our responsibility to continue educating research communities and the broader public on the impact of OA, especially in emerging and high-growth academic markets.

Spotlight on Malaysia

Malaysia continues to rise as a regional research hub, with five universities ranked in the global top 200 and 11 subjects in the global top 50. In 2024, Malaysia ranked 2nd in Southeast Asia in total publication output, 10th in Asia, and 25th globally.

MDPI’s presence in Malaysia:

  • Over 21,000 research articles published to date from Malaysian institutions
  • More than 1,100 articles published in 2024 alone
  • In the period 2020–2024, 54% of Malaysia’s total publications were OA
  • 36 EBMs from Malaysia, across 27 MDPI journals
  • Around 100 conferences sponsored in Malaysia in the past five years
  • MDPI is hosting the 2nd International Conference on AI Sensors and Transducers in Kuala Lumpur (29 July- 3 August 2025)

Media Coverage & Editorial Voices

Following the roundtable, we saw positive coverage across several local outlets, with articles highlighting MDPI’s role in empowering Malaysian researchers. Notable pieces included:

Our local EBMs also shared their perspectives:

Prof. Denny Ng Kok Sum (Sunway University, EBM of MDPI journal Processes) and Prof. Lee (EBM of MDPI journal Bacteria) share their experiences with MDPI and the role Open Access plays in their publication decisions.

“We see it as our responsibility to continue educating research communities on the impact of OA”

“I didn’t want my work stuck behind a paywall.”
— Prof. Denny Ng Kok Sum, Sunway University, Processes Editorial Board Member

“Open Access opens doors for collaboration and visibility, especially in fast-developing regions like ours.”
— Prof. Lee, Bacteria Editorial Board Member

This roundtable marked another step in building trust, understanding, and collaboration in Southeast Asia. A big thank-you to the MDPI Malaysia team and all those who contributed to the event’s success.

Closing Thoughts

MDPI Signs First North American Agreement with Canadian Consortium

We are proud to announce a major milestone for MDPI Canada and an important step forward for OA in North America.

In July, our Toronto office finalized MDPI’s first North American consortium agreement with the Federal Science Libraries Network (FSLN). This is a significant achievement that strengthens our expansion in Canada and reinforces our global commitment to supporting Open Science.

This two-year agreement gives Canadian federal agencies access to MDPI’s IOAP, including discounted article processing charges for affiliated researchers across our portfolio of over 475 OA journals. It lowers barriers for Canadian scientists to share their work more openly and reach a global audience.


Ryan Siu, Institutional Partnerships Manager at MDPI.

“The Open Science landscape in Canada is rapidly evolving, with the Tri-Agency Open Access Policy set for renewal by the end of 2025. This reflects ongoing efforts to foster greater scientific transparency and accessibility at a national policy level,” says Ryan Siu, Institutional Partnerships Manager at MDPI.

“Our new agreement with FSLN represents our shared commitment to further these efforts and foster wider readership. By aligning with these initiatives, we make progress towards research that’s both inclusive and impactful, benefiting local and global communities alike.”

Participating FSLN institutions include:

  • Agriculture and Agri-Food Canada
  • Environment and Climate Change Canada
  • Health Canada
  • National Research Council Canada
  • Natural Resources Canada

By partnering with some of Canada’s largest science-based agencies, we reaffirm our goal of advancing OA across continents. We look forward to developing our support for Canadian researchers and continuing to drive progress in Open Science across North America and beyond.

Stefan Tochev
Chief Executive Officer
MDPI AG

30 July 2025
Meet Us at the 18th Academic Symposium of the Veterinary Pharmacology and Toxicology Branch of the Chinese Association of Animal Science and Veterinary Medicine, 19–22 August 2025, Chengdu, China


MDPI will be attending the 18th Academic Symposium of the Veterinary Pharmacology and Toxicology Branch of the Chinese Association of Animal Science and Veterinary Medicine, which will be held from 19 to 22 August 2025, in Chengdu, China.

This conference will be hosted by Sichuan Agricultural University. It will invite well-known domestic experts to deliver academic reports on the latest advancements, new methods, and cutting-edge technologies in veterinary pharmacology and toxicology research. Academic exchanges and discussions will also be held on hot issues such as new veterinary drug research and development, food safety evaluation, and drug resistance prevention and control.

The conference will set up multiple parallel sessions, including “Pharmacodynamic and Mechanism of Action”, “Toxicology and Its Mechanism of Action”, “Bacterial Resistance”, “Veterinary Drug Residues and Food Safety”, and “Innovation and Application of New Veterinary Drugs”. Approximately 100 experts and young scholars will give special presentations.

The following MDPI journals will be represented:

If you plan on attending this conference, please feel free to stop by our booth and have a conversation with us. Our delegates look forward to meeting you in person and answering any questions that you may have. For more information about the conference, please visit the following link:

https://mm.sciconf.cn/cn/minisite/index/29384.

29 July 2025
Meet Us at the ASHG 2025 Annual Meeting, 14–18 October 2025, Boston, USA


Conference:
ASHG 2025 Annual Meeting
Organization: American Society of Human Genetics
Date: 14–18 October 2025
Place: Boston, USA

MDPI will attend the ASHG 2025 Annual Meeting, held in Boston, USA, from 14 to 18 October 2025.

The ASHG Annual Meeting is the largest human genetics and genomics meeting and exposition in the world. Held in the fall, it provides a forum for the presentation and discussion of cutting-edge science in all areas of human genetics. Highlights include invited symposia; abstract-driven plenary, platform, and poster sessions; education/trainee workshops; and career opportunities and networking events.

The following MDPI journals will be represented:

  • Genes;
  • Biomedicines;
  • IJMS;
  • Biomolecules;
  • BioMedInformatics;
  • Applied Biosciences;
  • DNA;
  • Cardiogenetics;
  • Vaccines;
  • Epigenomes;
  • Biology;
  • CIMB;
  • Diseases;
  • J;
  • JPM.

If you plan on attending this conference, please stop by our booth #1975 and speak with us. Our delegates look forward to meeting you in person and answering any questions that you may have.

For more information about the conference, please visit the following website: https://www.ashg.org/meetings/2025meeting/.

10 July 2025
Vaccines | Section Restructuring

The journal Vaccines (ISSN: 2076-393X) is organized into topical Sections focusing on specific research areas within vaccine research, utilization, and immunization. Under the guidance of Editor-in-Chief Prof. Dr. Ralph A. Tripp and the Section Editors-in-Chief, the journal has decided to reorganize its topical sections to enhance navigation for authors and readers. The table below outlines both the original and the new section structures.

  Original Sections New Sections
1. “Vaccines against Infectious Diseases” “Vaccines against Tropical and Other Infectious Diseases”
2. “Vaccines against Tropical and Other Infectious Diseases” “Vaccination Against Cancer and Chronic Diseases”
3. “Therapeutic Vaccines and Antibody Therapeutics” “Influenza Virus Vaccines”
4. “Cancer Vaccines and Immunotherapy” “HIV Vaccines”
5. “Influenza Virus Vaccines” “Human Papillomavirus Vaccines”
6. “HIV Vaccines” “Hepatitis Virus Vaccines”
7. “Human Papillomavirus Vaccines” “COVID-19 Vaccines and Vaccination”
8. “Hepatitis Virus Vaccines” “Veterinary Vaccines”
9. “COVID-19 Vaccines and Vaccination” “Epidemiology and Vaccination”
10. “Veterinary Vaccines” “Vaccines and Public Health”
11. “Epidemiology” “Vaccine Design, Development, and Delivery”
12. “Human Vaccines and Public Health” “Vaccines, Clinical Advancement, and Associated Immunology”
13. “Vaccine Adjuvants” “Pathogens-Host Immune Boundaries”
14. “Attenuated/Inactivated/Live and Vectored Vaccines” “Vaccine Advancement, Efficacy and Safety”
15. “Innate and Adaptive Immunity in Vaccination” “Nucleic Acid (DNA and mRNA) Vaccines”
16. “Clinical Immunology”  
17. “Cellular/Molecular Immunology”  
18. “Pathogens-host Immune Interface”  
19. “Vaccination Optimization”  
20. “Vaccine Efficacy and Safety”  
21. “DNA and mRNA Vaccines”  

For more detailed information, please visit the following link: https://www.mdpi.com/journal/vaccines/sections. The Special Issues and their respective publications in the original Sections will be transferred to the new Sections.

Vaccines Editorial Office

4 July 2025
MDPI’s Newly Launched Journals in June 2025

Six new journals covering a range of subjects launched their inaugural issues in June 2025. We are excited to be able to share with you the newest research rooted in the value of open access. We are pleased to present the latest research and to make it accessible to all.

We extend our sincere thanks to all the Editorial Board Members for their commitment and expertise. Each journal is dedicated to upholding strong editorial standards through a thorough peer review process, ensuring impactful open access scholarship.

Please feel free to browse and discover more about the new journals below.

Journal Founding Editor-in-Chief Journal Topics (Selected)
Prof. Dr. Chang-Pu Sun,
China Academy of Engineering Physics, Beijing, China; Computational Science Research Center, China
Editorial | View inaugural issue
quantum information and phenomena; condensed matter physics and statistical physics; atomic, molecular, and optical physics; computational physics and mathematical methods
View journal scope | Submit an article
Prof. Dr. Hualiang Lin,
Sun Yat-sen University, China;
Prof. Dr. Jose L. Domingo,
Universitat Rovira i Virgili, Spain
Editorial | View inaugural issue
green and organic food; green infrastructures; green exercise; environmental impact of the healthcare sector; effects of climate change on human health |
View journal scope | Submit an article
Prof. Dr. Francesco Veglio,
University of L’Aquila, Italy
Editorial | View inaugural issue
ultra-pure substances; water purification; air purification; gas purification; inorganic chemical purification; purification technologies
View journal scope | Submit an article
Prof. Dr. Junxing Zheng,
Huazhong University of Science and Technology, China
Editorial | View inaugural issue
computer-aided design and engineering; artificial intelligence and machine learning; building information modeling (BIM) and digital twins; robotics and automation in construction; smart sensors and Internet of Things (IoT); intelligent control systems and facilities management
View journal scope | Submit an article
Prof. Dr. Assunta Di Vaio, University of Naples Parthenope, Italy
Editorial | View inaugural issue
sustainability, managerial, and biodiversity accounting; carbon management accounting; corporate social responsibility; artificial intelligence and disclosure
View journal scope | Submit an article
Prof. Dr. Changjun Liu,
Sichuan University, China
Editorial | View inaugural issue
bioeffects of electromagnetic waves; electromagnetic science and engineering; microwave, millimeter-wave, and terahertz technologies; metamaterials and metasurfaces; communication, sensing, and networks; energy, power, and sustainable applications; quantum and emerging technologies; artificial intelligence and advanced fabrication
View journal scope | Submit an article
We wish to thank everyone who has supported the development of open access publishing. If you are interested in launching a new open access journal with us, you are welcome to send an application here.

2 July 2025
Meet Us at the 8th International Conference on Prevention & Infection Control, 16–19 September 2025, Geneva, Switzerland


Conference:
The 8th International Conference on Prevention & Infection Control
Date: 16–19 September 2025
Location: Geneva, Switzerland

MDPI will be attending the 8th International Conference on Prevention & Infection Control (ICPIC), which will be held between 16 and 19 September 2025, as an exhibitor. We welcome researchers from various backgrounds to visit our booth and share their latest ideas with us.

ICPIC stands as the premier gathering for the global infection prevention and control (IPC) community, dedicated to advancing the field through cutting-edge research, innovative solutions, and the exchange of invaluable experiences. Our mission remains steadfast: to prevent healthcare-associated infections and control antimicrobial resistance, in addition to improving patient and healthcare worker safety worldwide. This year, our conference will delve into an array of crucial topics, including hand hygiene, artificial intelligence (AI)/machine learning, antibiotic stewardship, surgical site infection prevention, new techniques and approaches in environmental hygiene, environmental responsibility and eco-friendly solutions in IPC, and diagnostic as well as clinical microbiology challenges for IPC.

We eagerly anticipate your participation at the conference and look forward to welcoming you to Geneva. Please mark your calendars and prepare for an inspiring and enriching event.

The following MDPI journals will be represented at the conference:

If you are planning to attend this conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information, please visit https://conference.icpic.com/.

2 July 2025
MDPI INSIGHTS: The CEO's Letter #24 - 2024 Impact Factor & CiteScore, MDPI Summits France & USA, Tu Youyou Award

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

MDPI’s 2024 Impact Factor Highlights

For those of our readers who are new to academic publishing, you may have heard some news in June around the Impact Factor release. Every year, typically in June, Clarivate releases its annual Journal Citation Reports (JCR), which include Journal Impact Factors (JIF). This metric is widely used in academic publishing to reflect the average number of citations received by recent articles in each journal.

While Impact Factor is just one of many indicators of journal influence, it remains a major milestone for authors, editors, and publishers. It’s used to assess journal visibility, researcher recognition, and scholarly reach. Throughout our international meetings and events, it’s clear that the Impact Factor is something many of our authors and editorial board members care about, as it can influence where they choose to submit an article and the funding they receive for their research.

“These results reflect the trust that the scholarly community places in MDPI”

MDPI’s 2024 Impact Factor Highlights

  • 298 MDPI journals received a Journal Impact Factor.
  • 60 journals earned their first-ever Impact Factor
    • To put this in perspective: MDPI’s 60 new journal acceptances into the Web of Science was the second highest number of any publisher in 2024, behind Elsevier and ahead of Springer Nature. Our 87% acceptance rate for journals submitted to Web of Science shows the strength of our editorial process and our proven ability to develop journals aligned with Clarivate’s 24 evaluation criteria.
    • Notably, Textiles, Mathematics, International Journal of Neonatal Screening, Smart Cities, Systems, and Pharmaceutics ranked in the top 10% in their respective categories, highlighting their growing influence and prestige within their academic fields. This shows that high-quality indexing goes beyond visibility; it upholds credibility and trust.
  • 193 MDPI journals are now ranked in the top 50% (Q1/Q2) of their subject categories.
    • What does this mean, and why is it important? Journals are ranked by quartiles within their field, based on their Impact Factor. Q1 represents the top 25% of journals in their category, Q2 the next 25%, and so on. Being in Q1 or Q2 shows that a journal is performing well relative to other journals in its category. Authors and institutions often look at quartile rankings when choosing where to publish – it’s an important indicator of visibility and recognition, within its respective category.
  • 116 of our previously ranked journals increased their Impact Factor.
  • 14 MDPI journals achieved an Impact Factor of 5.0 or higher, suggesting a high degree of influence and visibility.

These results reflect our staff's hard work: from our editorial and production teams to our indexing, communications, and data teams, and beyond. This also reflects the trust that the scholarly community places in MDPI, reinforcing the message that when researchers publish with MDPI, they publish with impact.

Open Access with Impact

As the leading fully open access publisher, our journals have received a total of 18.4 million citations in the Web of Science by the end of 2024, reflecting the growing reach and engagement of research published with MDPI. We are committed to making scientific research freely accessible to everyone, everywhere. With the support of more than 4.2 million contributing authors, we’re proud to support the global shift toward open access.

Further Reading

If you’d like to better understand how journals get indexed and why Impact Factors matter, please read this recent interview with Dr. Constanze Schelhorn (Head of Indexing). It gives you a behind-the-scenes look at the role our indexing team plays in supporting journal indexing and visibility.

You can also read our official news announcement shared last week: MDPI Journals in the 2024 Journal Citation Reports.

Thank you to everyone, from our authors and reviewers to our editors and internal teams, who contributed to the progress of our journal indexing in 2024. We’re continuing to build journals that are recognized and trusted across disciplines.

Impactful Research

MDPI Journals See Continued Growth in 2024 CiteScore Results

Continuing our indexing updates, I’m pleased to share that MDPI has achieved strong results in the latest CiteScore metrics, released on 5 June by Scopus. These results reflect the collective efforts of our editors, reviewers, authors, and internal teams, with their dedication to quality and visibility in scientific publishing. You can read the full announcement here.

2024 Highlights:

  • 322 MDPI journals received a CiteScore (up from 274 last year).
  • 283 journals (88%) are ranked in Q1 or Q2 of their subject categories.
  • 237 journals (85%) saw an increase in their CiteScore compared to last year.
  • 48 journals received a CiteScore for the first time.
  • 39 journals are now placed in the top 10% of their subject areas.

“This growth highlights our commitment to supporting open, trusted science”

What is CiteScore and how is it measured?

CiteScore metrics are developed by Elsevier as an alternative to the Impact Factor. They measure the citation impact of journals and can be accessed freely on Scopus. The metric represents the yearly average number of citations to recent articles published in a journal. If you’re interested in learning more about citation metrics and how we use them, check out this blog post.

Why is this important?

These results show the growing recognition for, and impact of, MDPI journals across disciplines. CiteScore rankings help researchers, institutions, and funders assess where high-quality work is being published. This growth improves our journals’ positioning in the publishing landscape and highlights our commitment to supporting open, trusted science.

Inside MDPI

Highlights from the MDPI USA Summit in Boston (5–6 June)

With several Summits already behind us, I think this is a good time to reflect on the purpose of these Summits.

Why do we organize MDPI Summits?

These one-and-a-half-day, invite-only gatherings are designed to improve our relationships with Chief Editors who lead our journals and are respected voices in their fields. The Summits aim to:

  1. Share MDPI’s values, achievements, editorial practices, and local market collaborations.
  2. Collect feedback on MDPI operations and journal practices.
  3. Empower Chief Editors to confidently represent MDPI beyond the Summit.

While Chief Editors know their journals well, these events help them better understand MDPI. We want them to be ambassadors for our brand. The aim is for them to walk away informed, engaged, and equipped to share positively about MDPI.

About the Boston Summit

Held on 5–6 June, our first USA Summit gathered over 25 Chief Editors to learn more about MDPI’s activities and collaborations in the USA. The program included presentations, Q&A, and a panel discussion.

Agenda Highlights:

Moderated by Summer Huggard (Operations Manager [Toronto], MDPI), the program featured:

  • MDPI Overview and USA Collaboration – Stefan Tochev (CEO, MDPI)
  • AI in Publishing and MDPI's Actions – Feichi Lu (Junior Data Scientist, MDPI)
  • MDPI Editorial Process and Research Integrity – Dr. Giulia Stefenelli (Scientific Communications Lead, MDPI)
  • Panel Discussion – Stefan, Feichi, Giulia, Claudia
  • Society Partnerships – Dr. Clàudia Aunós (Society Partnerships Senior Manager, MDPI)
  • Voice of the Customer and Closing Remarks – Stefan Tochev (CEO, MDPI)

MDPI & the USA: Facts and Figures

  • With over 216,000 publications, the USA is MDPI’s second-largest contributor after China.
  • In 2024, the USA ranked 2nd in total submissions and 2nd in total MDPI publications, with more than 28,200 publications.
  • As of 2020, the cumulative number of authors from the USA until April 2025 was 352,099.
  • As at April 2025, there are more than 12,035 active Editorial Board Members (EBMs) from the USA, with 55% having an H-index over 26.
  • Among them, 96 serve as Editors-in-Chief (EiC) and 218 as section-Editors-in-Chief (SEiC)
  • MDPI has more than 920 Institutional Open Access Program agreements worldwide, with over 130 from the USA.

A special thanks to our Toronto team, and everyone who worked behind the scenes to make this event run smoothly.

Coming Together for Science

Highlights from the MDPI France Summit in Paris (12–13 June)

We completed our first MDPI France Summit in Paris last week, and it was a special event. Attendees were engaged from beginning to end, remaining after hours to network and collaborate.

Why a France Summit?

We chose to host a France Summit in view of the recent challenges MDPI has faced with the National Centre for Scientific Research (CNRS). What we took away from the event is that our authors and editors very much appreciate and enjoy working with us, but we need to address the concerns raised by CNRS, around Article Processing Charges (APCs) and the funding of gold open access publications.

“Our authors and editors very much enjoy working with us”

Some of the claims made in the June 2023 interview with Alain Schuhl, the Deputy CEO for Science at the CNRS, are simply not factual. For example, they state that MDPI’s “average APC charges per article are now around the same as Springer Nature’s.” Here is the relevant passage, reproduced verbatim:

This is not accurate.

A recent preprint analysing APC data from Elsevier, Springer Nature, Wiley, PLOS, MDPI, and Frontiers (2019–2023) shows that MDPI’s average APCs remain significantly lower than those of Springer Nature and several other major publishers.

The MDPI Summits are part of our outreach and communication efforts to address misconceptions and clarify MDPI’s position as one of the most accessible and affordable major gold open access publishers in the world.

Summit Overview

Held on 12–13 June, the France Summit gathered over 20 Chief Editors to learn more about MDPI’s activities and collaborations in France. Many of these editors are influential in their institutions and professional societies. Several also have connections to CNRS, which makes this an important opportunity to clarify how we operate and build trust through open and transparent communication and hopefully turn our editors into informed advocates of MDPI.

Summit Feedback

The feedback has been very positive, with most attendees completing the post-event survey and all rating the experience as Excellent or Good. A few highlights:

  • “The whole thing was highly professional and, above all, provided quantified details that will allow us to better answer questions surrounding MDPI.”
  • “The summit was an opportunity to meet personally various people directly engaged in the organization and policies of MDPI, which made it possible to clarify some important points concerning publishing with MDPI.”
  • “Very well organized! A great opportunity to see all French MDPI partners and editors.”

Program Highlights:

Moderated by Miruna Adelina Nicolcioiu (Senior Conference Producer), the program featured:

  • MDPI Overview and France Collaboration – Stefan Tochev (CEO)
  • MDPI Editorial Process and Peer-Review Quality – Dr. Marta Colomer (Public Affairs Specialist)
  • Institutional Partnerships and Open Access Funding Models – Becky Castellon (Institutional Partnerships Manager)
  • AI in Publishing and MDPI's Actions – Daniele Raimondi (Data Scientist)
  • Publication Ethics: Global Trends – Diana Cristina Apodaritei (Research Integrity Specialist)
  • Closing Remarks – Stefan Tochev
  • Panel Discussion – Diana, Becky, Prof. Dr. Patrick Da Cost, and Stefan

MDPI & France: Facts and Figures

  • With over 51,000 publications, France is MDPI's tenth-largest contributor, and fifth largest among EU countries after Italy, Spain, Germany, and Poland.
  • As of 2020, the cumulative number of authors from France until April 2025 was 87,592.
  • As at April 2025, there are more than 2,800 active Editorial Board Members (EBMs) from France, with 59% having an H-index over 26.
  • Among them, 22 serve as Editors-in-Chief (EiC) and 61 as section-Editors-in-Chief (SEiC)
  • In 2024, IJMS, JCM, and Molecules were the top three MDPI journals in terms of submissions from French-affiliated authors.

Special thanks to our colleagues from Romanian offices for organizing this successful event.

Closing Thoughts

Richard DiMarchi and Rolf Müller Share the 2024 Tu Youyou Award

As we wrap up this month’s newsletter, I’d like to take a moment to recognize the winners of the 2024 Tu Youyou Award, presented by our journal Molecules. I am pleased to share that the 2024 Tu Youyou Award has been conferred upon Richard DiMarchi and Rolf Müller, in recognition of their significant contributions to natural products chemistry and medicinal chemistry.

I invite you to read the editorial co-authored by the Tu Youyou Award Committee, which highlights the significance of the award and the remarkable impact of the recipients’ research.

A sincere thank-you to the 2024 Award Committee for their dedication and selection process, and congratulations once again to this year’s honourees. Your work exemplifies the kind of research MDPI is proud to support and amplify.

About the Tu Youyou Award
The 2024 Tu Youyou Award includes a total monetary prize of 100,000 Swiss Francs and a medal for each recipient. Established in 2016 to honour the pioneering spirit of Nobel laureate Tu Youyou, the Tu Youyou Award is an international award recognizing exceptional scholars dedicated to the fields of natural products chemistry and medicinal chemistry.

For further information about the award and the winners, please visit the Tu Youyou Award website.

Stefan Tochev
Chief Executive Officer
MDPI AG

28 June 2025
Meet Us at the 17th Academic Conference of the Chinese Pharmacological Society, 22–26 July 2025, Xiong An, China


Conference:
The 17th Academic Conference of the Chinese Pharmacological Society

Date: 22–26 July 2025

Location: Xiong An, China

MDPI will be attending the 17th Academic Conference of the Chinese Pharmacological Society as an exhibitor, which will be held from 22 to 26 July 2025. We welcome researchers from diverse backgrounds to attend and share their latest ideas with us.

The year 2025 marks the 40th anniversary of the establishment of the Chinese Pharmacological Society. We are pleased to attend the conference, which will systematically summarize the experience of the Chinese Pharmacological Society’s construction and development over the past 40 years. The 17th Academic Conference of the Chinese Pharmacological Society serves as an interdisciplinary forum for the prompt exchange of recent achievements, experiences, theories, technologies, and methods in China's pharmacology research domain, in addition to new drug development and related fields, The conference will promote the innovative development of China's pharmacology research and new drug development on a longer-term basis. Your participation will significantly contribute to the medical discourse and enhance the conference’s impact within the pharmacological field.

The following MDPI journals will be represented at the conference:

If you are planning to attend the above conference, please do not hesitate to start an online conversation with us. Our delegates look forward to meeting you in person at the booth and answering any questions that you may have. For more information about the conference, please visit the following website: https://mm.sciconf.cn/cn/web/index/29613?pc=1.

26 June 2025
Vaccines | Notable Papers Published in 2024 in the “Epidemiology” Section

1. “Herpes Zoster Vaccine Uptake and Active Campaign Impact, a Multicenter Retrospective Study in Italy”
by Andrea Ceccarelli, Federica Tamarri, Raffaella Angelini, Elizabeth Bakken, Ilaria Concari, Elsa Giannoccaro, Giada Domeniconi, Michela Morri, Chiara Reali, Francesca Righi et al.
Vaccines 2024, 12(1), 51; https://doi.org/10.3390/vaccines12010051
Full text available online: https://www.mdpi.com/2076-393X/12/1/51

2. “Sustaining the Elimination of Measles, Rubella and Congenital Rubella Syndrome in the Americas, 2019–2023: From Challenges to Opportunities”
by Gloria Rey-Benito, Desirée Pastor, Alvaro Whittembury, Regina Durón, Carmelita Pacis-Tirso, Pamela Bravo-Alcántara, Claudia Ortiz and Jon Andrus
Vaccines 2024, 12(6), 690; https://doi.org/10.3390/vaccines12060690
Full text available online: https://www.mdpi.com/2076-393X/12/6/690

3. “Possible Paths to Measles Eradication: Conceptual Frameworks, Strategies, and Tactics”
by Amy K. Winter and William J. Moss
Vaccines 2024, 12(7), 814; https://doi.org/10.3390/vaccines12070814
Full text available online: https://www.mdpi.com/2076-393X/12/7/814

4. “Congenital Rubella Syndrome Does Not Increase with Introduction of Rubella-Containing Vaccine”
by Kurt Frey
Vaccines 2024, 12(7), 811; https://doi.org/10.3390/vaccines12070811
Full text available online: https://www.mdpi.com/2076-393X/12/7/811

5. “The Global Measles and Rubella Laboratory Network Supports High-Quality Surveillance”
by Paul A. Rota, Roger Evans, Myriam Corinne Ben Mamou, Gloria Rey-Benito, Lucky Sangal, Annick Dosseh, Amany Ghoniem, Charles R. Byabamazima, Maurice Demanou, Raydel Anderson et al.
Vaccines 2024, 12(8), 946; https://doi.org/10.3390/vaccines12080946
Full text available online: https://www.mdpi.com/2076-393X/12/8/946

6. “An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity”
by Emma Chang-Rabley, Menno C. van Zelm, Emily E. Ricotta and Emily S. J. Edwards
Vaccines 2024, 12(6), 675; https://doi.org/10.3390/vaccines12060675
Full text available online: https://www.mdpi.com/2076-393X/12/6/675

7. “Assessment of Epidemiological Trend of Influenza-Like Illness in Italy from 2010/2011 to 2023/2024 Season: Key Points to Optimize Future Vaccination Strategies against Influenza”
by Sara Boccalini and Angela Bechini
Vaccines 2024, 12(8), 841; https://doi.org/10.3390/vaccines12080841
Full text available online: https://www.mdpi.com/2076-393X/12/8/841

8. “Determinants of Systemic SARS-CoV-2-Specific Antibody Responses to Infection and to Vaccination: A Secondary Analysis of Randomised Controlled Trial Data”
by Juana Claus, Thijs ten Doesschate, Esther Taks, Priya A. Debisarun, Gaby Smits, Rob van Binnendijk, Fiona van der Klis, Lilly M. Verhagen, Marien I. de Jonge, Marc J. M. Bonten et al.
Vaccines 2024, 12(6), 691; https://doi.org/10.3390/vaccines12060691
Full text available online: https://www.mdpi.com/2076-393X/12/6/691

9. “Measles and Rubella Diagnostic and Classification Challenges in Near- and Post-Elimination Countries”
by Thomas D. Filardo, Stephen N. Crooke, Bettina Bankamp, Kelley Raines, Adria D. Mathis, Tatiana M. Lanzieri, R. Suzanne Beard, Ludmila Perelygina, David E. Sugerman and Paul A. Rota
Vaccines 2024, 12(6), 697; https://doi.org/10.3390/vaccines12060697
Full text available online: https://www.mdpi.com/2076-393X/12/6/697

10. “Serosurveillance for Measles and Rubella”
by Allison M. Brady, Elina El-Badry, Eriko Padron-Regalado, Nicole A. Escudero González, Daniel L. Joo, Paul A. Rota and Stephen N. Crooke
Vaccines 2024, 12(7), 816; https://doi.org/10.3390/vaccines12070816
Full text available online: https://www.mdpi.com/2076-393X/12/7/816

26 June 2025
Vaccines Receives an Updated Impact Factor of 3.4


We are pleased to share that Vaccines (ISSN: 2076-393X) was awarded an updated Impact Factor of 3.4 in the 2024 Journal Citation Reports™ released by Clarivate™ in June 2025. Vaccines ranks in Q2 (85 out of 183) in the “Immunology” category and Q2 (75 out of 195) in the “Medicine, Research and Experimental” category. Vaccines ranks in the first quartile (Q1) in these two JCI-indexed subject areas.

The 2024 Journal Impact Factor is calculated by dividing the number of citations received in 2024 to all publications in the journal from 2022 and 2023 by the total number of citable publications from those same years.

To learn more, visit our journal statistics website for detailed metrics or check out our news article for general information.

The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.

Back to TopTop